Somatic and germline heterogeneity across colorectal cancer patient characteristics: Implications for early cancer detection

Tailored oncology for all breast cancer patients

Haematology malignancies and cellular therapy

Immunotherapy developments and new agents for locally advanced NSCLC and SCLC

Challenges in interpreting comprehensive biomarker testing and a few paths to address them

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Predictive and prognostic biomarkers for immunotherapy in lung cancer

Updates in melanoma and skin cancers

Molecular oncology and translational medicine

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Pembrolizumab benefits patients with brain metastases

Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens